Document Detail

Improved treatment strategies reduce the increased mortality risk in early RA patients.
MedLine Citation:
PMID:  20696679     Owner:  NLM     Status:  In-Process    
OBJECTIVE: A higher mortality rate in patients with RA than in the general population has been reported in most series. Treatment strategies for RA have improved dramatically over the last decades, resulting in less inflammation and joint damage. We investigated whether this change in treatment corresponds to reversal of excess mortality by studying a large inception cohort of early RA patients exposed to different treatment strategies.
METHODS: Six hundred and eighty-four RA patients included in the Leiden Early Arthritis Clinic between 1993 and 2008 were studied. Treatment was different for three inclusion periods. From 1993 to 1995 patients were treated with NSAIDs and only late in their disease with DMARDs. From 1996 to 1998 patients were promptly treated with HCQ or SSZ. From 1999 to 2008 patients were immediately treated with MTX monotherapy or in combination with other disease-modifying drugs. Life/death status was tracked nationally using the civic registries. Mortality rates were compared with the general Dutch population.
RESULTS: In Periods 1 and 2, increased standardized mortality rates were found, 1.35 (95% CI 0.94, 1.93) and 1.23 (95% CI 0.91, 1.67), respectively, while a decreased standardized mortality rate was found for patients included in 1999-2006 [0.49 (95% CI 0.31, 0.77)]. Age of onset [hazard ratio (HR) 1.10 (95% CI 1.07, 1.13)], erosive disease [HR 2.03 (95% CI 1.22, 3.37)], high CRP level [HR 1.09 (95% CI 1.01, 1.18)], smoking [HR 2.39 (95% CI 1.31, 4.38)] and higher baseline HAQ score [HR 1.53 (95% CI 1.06, 2.20)] associated with mortality.
CONCLUSION: Current treatment strategies for early RA, such as that given in inclusion Period 3, might contribute to the reversal of excess mortality in RA.
Jessica A B van Nies; Zuzana de Jong; Annette H M van der Helm-van Mil; Rachel Knevel; Saskia Le Cessie; Tom W J Huizinga
Related Documents :
22281789 - Changes in bnp, hs-crp and timi risk index with addition of tirofiban during primary pe...
21067459 - Adherence and persistence of single-pill arb/ccb combination therapy compared to multip...
9774929 - Outcome from out-of-hospital cardiac arrest caused by nonventricular arrhythmias: contr...
22710999 - Amoxicillin-clavulanic acid hepatotoxicity in children.
22477369 - Functional outcome after femoral endarterectomy: a single-centre experience.
16435069 - Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated hear...
21455329 - Does deep sedation impact the results of 48 hours catheterless ph testing?
7609199 - Submucosal bladder neck injections of glutaraldehyde cross-linked bovine collagen for t...
1908799 - Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-09
Journal Detail:
Title:  Rheumatology (Oxford, England)     Volume:  49     ISSN:  1462-0332     ISO Abbreviation:  Rheumatology (Oxford)     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883501     Medline TA:  Rheumatology (Oxford)     Country:  England    
Other Details:
Languages:  eng     Pagination:  2210-6     Citation Subset:  AIM; IM    
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metast...
Next Document:  Impact of C-reactive protein on absolute reticulocyte count in haemodialysis patients: the role of i...